Immunopathogeny of immediate-type hypersensitivity, anaphylactic and anaphylactoid reactions;BASES IMMNOPATHOGENIQUES DES REACTIONS ALLERGIQUES, ANAPHYLACTIQUES ET ANAPHYLACTOIDES

JEUR

Volumn 11, Issue 1, 1998, Pages 12-20

  Ponvert, C ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; HISTAMINE; IMMUNOGLOBULIN E;

ALLERGIC REACTION; ANAPHYLAXIS; DIFFERENTIAL DIAGNOSIS; HUMAN; IMMEDIATE TYPE HYPERSENSITIVITY; MAST CELL; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW;

EID: 0031956093     PISSN: 09939857     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (34)

1. DASER L, MEISSNER N, HERTZ U et RENZ H. Role and modulation of T-cell cytokines in allergy Current Opin. Immunol 1995; 7: 762-70.
2. BERGER J, TAYTARD A et TUNON DE LARA JM. Cytokines et allergie immédiate: contrôle de la phase tardive. Rev franç Allergol 1996; 36: 298-304.
3. BORISH L et ROSENWASSER LJ. Update on cytokines. J Allergy Clin. Immunol 1996; 97: 719-34.
4. KING TP, HOFFMAN D, LOWENSTEIN, H et al. Allergen nomenclature. Int Arch. Allergy Immunol 1994; 105: 224-33.
5. LEDFORD DIS. Indoor allergens. J Allergy Clin Immunol 1994; 94: 327-34.
6. HEFLE SL. The molecular biology of food allergy. Immunol. Allergy Clin N Amer 1996; 16: 565-90.
7. ANDERSON JA. Allergic reactions to drugs and biological agents. J Amer Med Assn 1992; 268: 2845-57.
8. PORTIER P et RICHET C. De l'action anaphylactique de certains venins. CR Soc. Biol 1902; 54: 170.
9. DOMBROWICZ D, FLAMAND V, BRIGMAN KK et al. Abolition of anaphylaxis by targeted disruption of the high affinity immunoglobulin E receptor α chain gene. Cell 1993; 75: 969-76.
10. MONERET-VAUTRIN DA, ZANNAD F, KANNY G et THINUS G. L'anaphylaxie cardiaque. Rev franç Allergol 1996; 36: 497-502.
11. PATELLA V, MARINO I, LAMPARTER B et al. Human heart mast cells: isolation, purification, ultrastructure, and immunologic characterization. J Immunol 1995; 154: 2855-65.
12. LAROCHE D, DUBOIS F, LEFRANÇOIS C et al. Marqueurs biologiques précoces des réactions anaphylactoïdes peranesthésiques. Ann Fr Anesth Reamm 1992; 11: 613-8.
13. MARTIN TR, GALLI SJ, KATONA IM et DRAZEN JM. Role of mast cells in anaphylaxis: evidence for the importance of mast cells in the cardiopulmonary alterations and death induced by anti-IgE in mice J Clin Invest 1989; 83: 1375-83.
14. NAGY S. The role of histamine in shock. Acta Physiol Hung 1990; 76; 3-12.
15. MOSS J. The impact of histamine research on clinical anesthesia and surgery. Agents Actions 1992; Special Conference Issue: C135-C148.
16. FELIX SB. Effects of histamine H1-receptor blockade on respiratory and cardiac manifestation of systemic anaphylaxis. Agents Actions 1991; 33: 349-58.
17. BLANDINA P, BRUNELLESCHI S, FANTOZZI R, et al. The antianaphylactic action of histamine H2-receptor agonists in the guinea-pig isolated heart. Br J Pharmacol 1987; 90: 459-66.
18. KOSTIC MM et JAKOVLJEVIC VLJ. Role of histamine in the regulation of coronary circulation. Physiol Res 1996; 45: 297-303.
19. MITSUHATA H, SHIMIZU R et YOKOYAMA MM. Role of nitric oxide in anaphylactic shock. J Clin Immunol 1995; 15: 277-83.
20. OSADA S, ICHIKI H, OKU H et al. Participation of nitric oxide in mouse anaphylactic hypotension. Eur J Pharmacol 1994; 252: 347-50.
21. SAITOH J, MITSUHATA H, TAKEUCHI H et al. In vivo production of nitric oxide in the canine heart in IgE-mediated anaphylaxis. Shock 1996; 6: 66-70.
22. CHOI IH, HA Y, LEE DG et al. Occurence of disseminated intravascular coagulation (DIC) in active systemic anaphylaxis: role of platelet-activating factor. Clin Exp Immunol 1995; 100: 390-4.
23. TANNIÈRE M et ROCHETTE L. Direct effects of platelet-activating factor (PAF) on cardiac function in isolated guinea-pig heart. Drug Develop Res 1987; 11: 177-186.
24. YAACOB HB, GONG NH, SEAHMI MM et PIPER PJ. The release of leukotrienes and the vascular changes mediated by platelet-activating factor and cardiac anaphylaxis. Asia Pac J Pharmacol 1995; 10: 25-32.
25. DONG LW, CHANG YZ, TONG LJ et al. Role of regulatory peptide in pathogenesis of shock. Sci China 1994; 37: 162-9.
26. HERMANN K, EBNER VON ESSENBACH C, VON TSCHIRSCHNITZ, M et RING J. Plasma concentrations of arginin-vasopressin, oxytocin and angiotensin in patients with hymenoptera venom anaphylaxis. Regulat peptides 1993; 49: 1-7.
27. HERMANN K et RING J. Human leukocytes contain angiotensin I, angiotensin II and angiotensin metabolites. Int Arch Allergy Immunol 1994; 103: 152-9.
28. HERMANN K, VON TSCHIRSCHNITZ M, EBNER VON ESSENBACH C et RING J. Histamine, tryptase, norepinephrine, angiotensinogen, angiotensin-converting enzyme, angiotensin I and II in plasma of patients with hymenoptera venom anaphylaxis. Int Arch Allergy Immunol 1994; 104: 379-84.
29. HERMANN K, DONHAUSER S et RING J. Angiotensin in human leukocytes of patients with insect venom anaphylaxis and healthy volunteers. Int Arch Allergy Immunol 1995; 107: 385-6.
30. HERMANN K et RING J. The renin-angiotensin system in patients with repeated anaphylactic reactions during hymenoptera venom hyposensitization and sting challenge. Int Arch Allergy Immunol 1997; 112: 251-6.
31. PONVERT C, PAUPE J et SCHEINMANN P. Relations entre anaphylaxie et système neuro-endocrinien. Rev fr Allergol 1997; 37: 813-815.
32. Yocum MW et KHAN DA. Assessment of patients who have experienced anaphylaxis: a 3-year survey. Mayo Clin Proc 1994; 69; 16-23.
33. HADDI E, CHARPIN D, TAFFOREAU M et al. Atopy and systemic reactions to drugs. Allergy 1990; 45: 1-4.
34. VAN DER KLAUW MM, WILSON JHP et STRICKER BHC. Drug-associated anaphylaxis: 20 years of reporting in the Netherlands (1974-1994) and review of the litterature. Clin Exp Allergy 1996; 26: 1355-63.